News
-
-
PRESS RELEASE
Original-Research: Borussia Dortmund GmbH & Co KGaA (von NuWays AG): BUY
Update on Borussia Dortmund GmbH & Co KGaA from NuWays AG highlights expected benefits from structural changes including Bundesliga broadcasting rights and new UCL format. Sponsorship upside and recent UCL success also contribute to positive outlook -
-
-
-
-
PRESS RELEASE
BioNxt Reports Commercialization of ODF Cladribine Product for MS Next Steps
BioNxt Solutions Inc. reports progress in toxicity and PK studies, advancing towards human comparative bioavailability studies. Development includes technology transfer, upscaling, & clinical sample prep for bioequivalence study -
-
-